Nitric oxide inhibits the positive inotropic response to beta-adrenergic stimulation in humans with left ventricular dysfunction.
about
Regulation of cardiovascular cellular processes by S-nitrosylationThe cGMP signaling pathway as a therapeutic target in heart failure with preserved ejection fractionInotropic response to beta-adrenergic receptor stimulation and anti-adrenergic effect of ACh in endothelial NO synthase-deficient mouse heartsNitric oxide inhibition of adenylyl cyclase type 6 activity is dependent upon lipid rafts and caveolin signaling complexesInvolvement of iNOS in postischemic heart dysfunction of stroke-prone spontaneously hypertensive rats.Effect of dobutamine and hyperoxia on free radicals production in relation to the ultrastructural alterations in the endothelial of myocardial capillary in rats, Rattus norvigicus.The Renin-Angiotensin System in the Development of Salt-Sensitive Hypertension in Animal Models and Humans.Prologue: Nitric oxide--hormones, metabolism, and function.Heart failure and neuroendocrine activation: diagnostic, prognostic and therapeutic perspectives.Inhaled nitric oxide in cardiology.The nitric oxide pathway and oxidative stress in heart failure.Genetic polymorphisms and oxidative stress in heart failure.Cardiac endothelial-myocardial signaling: its role in cardiac growth, contractile performance, and rhythmicity.High-dose hydroxocobalamin administered after H2S exposure counteracts sulfide-poisoning-induced cardiac depression in sheepEffects of L-arginine on lower limb vasodilator reserve and exercise capacity in patients with chronic heart failureInhibition of nitric oxide synthesis improves left ventricular contractility in neonatal pigs late after cardiopulmonary bypass.Effects of sildenafil on ventricular and vascular function in heart failure with preserved ejection fraction.Sepsis-induced cardiomyopathy.Pathophysiology of sepsis-related cardiac dysfunction: driven by inflammation, energy mismanagement, or both?Type 5 phosphodiesterase inhibition in heart failure and pulmonary hypertension.The emerging role for type 5 phosphodiesterase inhibition in heart failure.beta(3)-adrenoceptor deficiency blocks nitric oxide-dependent inhibition of myocardial contractility.Pertussis toxin-sensitive G proteins influence nitric oxide synthase III activity and protein levels in rat heartThe negative inotropic effect of beta3-adrenoceptor stimulation is mediated by activation of a nitric oxide synthase pathway in human ventricle.Muscarinic cholinergic regulation of cardiac myocyte ICa-L is absent in mice with targeted disruption of endothelial nitric oxide synthase.Nitric oxide mechanisms of nebivolol.Inducible nitric oxide synthase inhibits oxygen consumption in collateral-dependent myocardiumNitric oxide inhibits creatine kinase and regulates rat heart contractile reserve.Pulmonary vasodilation in acute and chronic heart failure: empiricism and evidence.Pulmonary hemodynamic responses to inhaled NO in chronic heart failure depend on PDE5 G(-1142)T polymorphism.Sildenafil and B-type natriuretic peptide acutely phosphorylate titin and improve diastolic distensibility in vivo.Nitric oxide-dependent and -independent mechanisms are involved in TNF-alpha -induced depression of cardiac myocyte contractility.Differential effects of natriuretic peptides and NO on LV function in heart failure and normal dogs.No involvement of nitric oxide in the limitation of beta-adrenergic inotropic responsiveness during ischemia.Involvement of inducible nitric oxide synthase in cardiac dysfunction with tumor necrosis factor-alpha.The inotropic effect of nitric oxide on mammalian papillary muscle is dependent on the level of beta1-adrenergic stimulation.Inhaled nitric oxide modifies left ventricular diastolic stress in the presence of vasoactive agents in heart failure.Redox modulation of the inotropic response to dobutamine is impaired in patients with heart failure.Unequal effects of renin-angiotensin system inhibitors in acute cardiac dysfunction induced by isoproterenol.Fluvastatin reduces pulmonary vein spontaneous activity through nitric oxide pathway.
P2860
Q24300987-D19D21C7-105C-44C1-927B-EDA0F1EFD854Q27024279-75EE5C21-C8E9-45FB-B9DB-D0B4CA8C7E3BQ28365489-02640FDA-4EE0-46DA-B157-5B38B81DCDA1Q28573679-7354D5CF-C445-4DCA-9659-49C919E8ED40Q31833719-8F267477-EF66-46BF-B5EC-73E836CFCBC7Q33515392-158FEF2F-0832-4869-9157-136E8D97D7B5Q33664406-1E47F643-5065-4613-81B2-0145AF37E5B4Q34439901-E5FA4B24-604A-43BD-A546-D78A5E56D511Q34448373-5C619853-30A4-429C-BE27-4CF6847A16DEQ34481821-CB04FD35-7D16-44D4-B2A8-9399947A889CQ34667665-9ABB03D3-C9BC-4C45-A723-B2C45C50B357Q34667676-A9A7D10D-116D-426B-9B78-04AFA72E1FAAQ35035923-116098B8-ED70-4D63-AEB3-CE188EEF2465Q35096172-5B045FD3-3B82-4504-94CF-828CE02C38EFQ35371877-1EB07116-1264-4614-85B1-4F2667A7FCD6Q35374093-B4E4BBA4-CCC4-4754-91A1-ECC6A5496AC7Q35630046-49AA914B-FF76-4BE8-9529-54C215D6B0FFQ35687065-EF7DC5A0-5FCA-4FB7-8445-39F72D883033Q35761448-7A474790-2BA3-4D4B-B1F1-94DE71905735Q36203104-07205A59-5B6E-446A-A42A-B765CE885B29Q36567862-6596EA07-A0BF-4C7A-832D-6B280175A1F4Q37267545-4A0FE33B-AA44-4BC7-8673-69F4F7E8F487Q37379613-893D2230-C3D3-4F2C-9F95-B5E3A579626BQ37385274-694B8096-E54B-4745-A8F5-D9CF6AA64829Q37440090-DF51F795-DF66-44B9-B8C2-BC8FE2DD2BBBQ37483065-5E917B60-F7F0-4608-8B38-09428206CCE1Q37575908-5F7A061C-0584-4BF0-AD2C-31E54D0501DDQ37593617-D021269D-06BA-4D4C-9851-AEF851F8B1D2Q37873778-8DBFB369-B3EF-4F09-9E0A-E11DC8A29394Q39385171-38F0A772-5531-45C8-BA01-138D6ED0F469Q42149439-ADAA16F0-923D-465F-8C9E-183A84940286Q42507063-EFCC2DD3-F660-41EB-8C0B-83118819EA42Q43640255-35BC3D97-EE02-4B86-95F2-4AB4FD4579BBQ43799984-ED287401-E609-4289-BC6A-55CE4D412A74Q43988589-8C8E799C-314A-48EB-A9E6-C704EE0A0C91Q44063636-3FE9BC9E-C7EF-4CB1-AE36-DE799C7BDF23Q44273149-B323E526-6D61-434C-B148-36A823591601Q44612941-E3B7AF4E-AD27-4749-8653-EA3EF0B72825Q45009038-929FCF8B-367C-40BB-B6F7-5F16BF5D7310Q46385876-B4CD337A-696D-4B5F-BE6B-270E625F7EED
P2860
Nitric oxide inhibits the positive inotropic response to beta-adrenergic stimulation in humans with left ventricular dysfunction.
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
1995年论文
@zh
1995年论文
@zh-cn
name
Nitric oxide inhibits the posi ...... left ventricular dysfunction.
@en
type
label
Nitric oxide inhibits the posi ...... left ventricular dysfunction.
@en
prefLabel
Nitric oxide inhibits the posi ...... left ventricular dysfunction.
@en
P2093
P356
P1433
P1476
Nitric oxide inhibits the posi ...... left ventricular dysfunction.
@en
P2093
P304
P356
10.1161/01.CIR.92.8.2198
P407
P577
1995-10-01T00:00:00Z